{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:07:55Z","timestamp":1753877275116,"version":"3.41.2"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,9]]},"abstract":"<jats:p>Teaser A new engineered human immunoglobulin (Ig)G anti-yellow fever virus monoclonal antibody suggested potential clinical benefit in Phase 1a and 1b clinical trial.<\/jats:p>","DOI":"10.1093\/jtm\/taaa164","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T12:21:29Z","timestamp":1600345289000},"source":"Crossref","is-referenced-by-count":0,"title":["Engineered human immunoglobulin anti-yellow fever virus monoclonal antibodies to treat severe yellow fever"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2305-1196","authenticated-orcid":false,"given":"W Y","family":"Leong","sequence":"first","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"2020110901125156800_ref1","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay097","article-title":"Pandemic yellow fever: a potential threat to global health via travelers","volume":"25","author":"Gubler","year":"2018","journal-title":"J Travel Med"},{"key":"2020110901125156800_ref2","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz043","article-title":"Managing severe yellow fever in the intensive care: lessons learnt from Brazil","volume":"26","author":"Kallas","year":"2019","journal-title":"J Travel Med"},{"key":"2020110901125156800_ref3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4269\/ajtmh.2004.71.306","article-title":"Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease","volume":"71","author":"Sbrana","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"2020110901125156800_ref4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJMoa2000226","article-title":"Phase 1 trial of a therapeutic anti-yellow fever virus human antibody","volume":"383","author":"Low","year":"2020","journal-title":"N Engl J Med"},{"key":"2020110901125156800_ref5","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz024","article-title":"Fractional-dose yellow fever vaccination: an expert review","volume":"26","author":"Roukens","year":"2019","journal-title":"J Travel Med"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taaa164\/33921119\/taaa164.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jtm\/article-pdf\/27\/7\/taaa164\/34162032\/taaa164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jtm\/article-pdf\/27\/7\/taaa164\/34162032\/taaa164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T06:13:03Z","timestamp":1604902383000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taaa164\/5908537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":5,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,9,18]]},"published-print":{"date-parts":[[2020,11,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taaa164","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"type":"print","value":"1195-1982"},{"type":"electronic","value":"1708-8305"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,9,18]]},"article-number":"taaa164"}}